Authors
Loading...
Retrospective analysis compares efgartigimod and IVIg in Guillain–Barré syndrome, suggesting potential benefits of efgartigimod.
Zhang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: